Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Apixaban Anti-Xa Level Monitoring in Treatment of Provoked Acute Upper Extremity Deep Vein Thrombosis for Patient on Dialysis: A Case Report

Guillaume Roberge, MD, Philip S. Wells, MDMSc,FRCP

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-141911

Published: 2020

Journal Articles

Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer

Joseph R. Shaw, MD, Ranjeeta Mallick, PhD MSc, BSc, Marc Carrier, MD, Anton Ilich, MD, Nigel S. Key, MBChB, FRCP, Philip S. Wells, MDMSc,FRCP

Blood (2019) 134 (Supplement_1): 634.

https://doi.org/10.1182/blood-2019-126306

Published: 2019

Journal Articles

Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial

Marina Atalla, James Zhang, MD, Ranjeeta Mallick, PhD MSc, BSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD

Blood (2019) 134 (Supplement_1): 3660.

https://doi.org/10.1182/blood-2019-122970

Published: 2019

Journal Articles

Safety and Efficacy of Apixaban Thromboprophylaxis in Cancer Patients with Metastatic Disease: A Subgroup Analysis of the Avert Trial

William Knoll, BSc, Ranjeeta Mallick, PhD MSc, BSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD

Blood (2019) 134 (Supplement_1): 1140.

https://doi.org/10.1182/blood-2019-128834

Published: 2019

Journal Articles

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Miriam Kimpton, MD, Srishti Kumar, MSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD, Kednapa Thavorn, MPharm, PhD

Blood (2019) 134 (Supplement_1): 329.

https://doi.org/10.1182/blood-2019-127286

Published: 2019

Journal Articles

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

Yan Xu, MD, Tara Gomes, PhD MHSc, Philip S. Wells, MDMSc,FRCP, Ana Johnson, PhD, Michelle Sholzberg, MD

Blood (2018) 132 (Supplement 1): 426.

https://doi.org/10.1182/blood-2018-99-111207

Published: 2018

Journal Articles

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Michael J. Kovacs, MD, Marc Rodger, MDMSc, Philip S. Wells, MDMSc,FRCP, Shannon M. Bates, MD MSc, Clive Kearon, MB, PhD, Mark Blostein, MDFRCPC, Alejandro Lazo-Langner, MD MSc, Susan Kahn, MD, Sam Schulman, MD PhD FRCPC, Elham Sabri, MSc, Susan Solymoss, MD, Timothy Ramsay, PhD, Luljeta Pallaveshi, RN, BA, David Anderson, MD

Blood (2018) 132 (Supplement 1): 424.

https://doi.org/10.1182/blood-2018-99-109964

Published: 2018

Journal Articles

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

Susan R Kahn, MD MSc, Andrew Hirsch, MD, Margaret Beddaoui, MSc, Arash Akaberi, MSc, David Anderson, MD, Philip S Wells, MDMSc, Marc Rodger, MD MSc, Susan Solymoss, MD, Michael J. Kovacs, MD, Lawrence Rudski, MD, Avi Shimony, MD, Carole Dennie, MD, Chris Rush, MD, William H. Geerts, MD, Paul Hernandez, MD, Shawn Aaron, MD, John T Granton, MD

Blood (2015) 126 (23): 649.

https://doi.org/10.1182/blood.V126.23.649.649

Published: 2015

Journal Articles

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

Blood (2015) 126 (23): 650.

https://doi.org/10.1182/blood.V126.23.650.650

Published: 2015

Journal Articles

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Alejandro Lazo-Langner, MD MSc, Susan R Kahn, MD MSc, Philip S Wells, MDMSc, David Anderson, MD, Marc Rodger, MD MSc, Marc Carrier, MD MSc, Annmarie A. Bosco, MBBS, BSc (MD, Judy Kovacs, RN, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2015) 126 (23): 893.

https://doi.org/10.1182/blood.V126.23.893.893

Published: 2015

Journal Articles

Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study

Blood (2015) 126 (23): 750.

https://doi.org/10.1182/blood.V126.23.750.750

Published: 2015

NARROW

Apixaban Anti-Xa Level Monitoring in Treatment of Provoked Acute Upper Extremity Deep Vein Thrombosis for Patient on Dialysis: A Case Report

Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer

Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial

Safety and Efficacy of Apixaban Thromboprophylaxis in Cancer Patients with Metastatic Disease: A Subgroup Analysis of the Avert Trial

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only